Molecular docking analysis of known flavonoids as duel COX-2 inhibitors in the context of cancer

被引：14

作者：

Dash, Raju ^{[1
]}

Uddin, Mir Muhammad Nasir ^{[2
]}

Hosen, S. M. Zahid ^{[3
]}

Bin Rahim, Zahed ^{[1
]}

Dinar, Abu Mansur ^{[4
]}

Kabir, Mohammad Shah Hafez ^{[5
]}

Sultan, Ramiz Ahmed ^{[2
]}

Islam, Ashekul ^{[6
]}

Hossain, Md Kamrul ^{[2
]}

机构：

[1] BGC Trust Univ Bangladesh, Dept Pharm, Chittagong 4000, Bangladesh

[2] Univ Chittagong, Dept Pharm, Chittagong 4331, Bangladesh

[3] BCSIR, Pharmacol Res Div, MMDDL, Chittagong 4220, Bangladesh

[4] Sq Pharmaceut Ltd, Qual Control Operat, Dhaka, Bangladesh

[5] Int Islamic Univ Chittagong, Dept Pharm, Chittagong 4203, Bangladesh

[6] Univ Chittagong, Dept Biochem & Mol Biol, Chittagong 4331, Bangladesh

来源：

BIOINFORMATION | 2015年 / 11卷 / 12期

关键词：

COX-2; FlexX; ArgusLab; Flavonoids; Cancer;

D O I：

10.6026/97320630011543

中图分类号：

Q [生物科学];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

Cydooxygenase-2 (COX-2) catalyzed synthesis of prostaglandin E2 and it associates with tumor growth, infiltration, and metastasis in preclinical experiments. Known inhibitors against COX-2 exhibit toxicity. Therefore, it is of interest to screen natural compounds like flavanoids against COX-2. Molmular docking using 12 known flavanoids against COX-2 by FlexX and of ArgusLab were performed. All compounds showed a favourable binding energy of >-10 KJ/mol in FlexX and > -8 kcal/mol in ArgusLab. However, this data requires in vitro and in vivo verification for further consideration.

引用

页码：543 / 549

页数：7

共 50 条

[31] COX-2 inhibitors
Seidenberg, BC
LANCET, 1999, 353 (9168): : 1978 - 1978
[32] Molecular docking studies of withanolides against Cox-2 enzyme
Prabhakaran, Yogeswaran
Dinakaran, Sathis Kumar
Macharala, Sravan Prasad
Ghosh, Somsubhra
Karanam, Sridevi Ranjitha
Kanthasamy, Naveena
Avasarala, Harani
PAKISTAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2012, 25 (03) : 595 - 598
[33] COX-2 inhibitors
Lloyd, AW
DRUG DISCOVERY TODAY, 1996, 1 (03) : 122 - 123
[34] COX-2 inhibitors
Becker, RC
TEXAS HEART INSTITUTE JOURNAL, 2005, 32 (03): : 380 - 383
[35] COX-2 inhibitors
Hawkey, CJ
LANCET, 1999, 353 (9149): : 307 - 314
[36] COX-2 inhibitors
Lloyd, AW
DRUG DISCOVERY TODAY, 1997, 2 (09) : 393 - 393
[37] COX-2 inhibitors
Lawrie, MM
MEDICAL JOURNAL OF AUSTRALIA, 2001, 174 (07) : 367 - 367
[38] Biochemistry of cyclooxygenase (COX)-2 inhibitors and molecular pathology of COX-2 in neoplasia
Fosslien, E
CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 2000, 37 (05) : 431 - 502
[39] Molecular profiling of bladder cancer xenografts treated with Cox-2 inhibitors.
Kikuchi, E
Sanchez-Carbayo, M
Choichiro, O
Ohori, M
Menendez, S
Cordon-Cardo, C
Bochner, BH
JOURNAL OF UROLOGY, 2005, 173 (04): : 164 - 164
[40] Docking studies of 1,5-diarylimidazole COX-2 inhibitors
Li, Shun-Lai
Zheng, Yan
Wang, Feng-Ying
Beijing Huagong Daxue Xuebao (Ziran Kexueban)/Journal of Beijing University of Chemical Technology (Natural Science Edition), 2006, 33 (04): : 75 - 79

← 1 2 3 4 5 →